Technology | Thrombectomy Devices

July 27, 2016 — Penumbra Inc. announced U.S. commercial availability of its latest thrombectomy device, the ACE68 ...

Home July 27, 2016
Home
News | Heart Valve Technology

Edwards Lifesciences Corp. announced that Health Canada has approved the Edwards Sapien 3 transcatheter heart valve for the treatment of patients living with severe, symptomatic aortic stenosis and at high or greater risk for surgical aortic valve replacement.

Home July 27, 2016
Home
News | Cath Lab

July 27, 2016 — A number of states mandate public reporting of mortality outcomes following certain cardiac procedures ...

Home July 27, 2016
Home
News | Genetic Testing

July 26, 2016 — A new study has identified a genetic error that weakens the aorta, placing patients with this and ...

Home July 26, 2016
Home
News | Stents Bioresorbable

On July 20, Massoud Leesar, M.D., of University of Alabama at Birmingham Hospital implanted a patient with Absorb, the world’s first U.S. Food and Drug Administration (FDA)-approved dissolving heart stent, for the first time in Alabama.

Home July 26, 2016
Home
News | Cardiovascular Business

July 25, 2016 — The Centers for Medicare and Medicaid Services (CMS) announced that it expects to launch its new Overall ...

Home July 26, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

July 26, 2016 — Hematology researchers at The Children’s Hospital of Philadelphia (CHOP) have developed a novel ...

Home July 26, 2016
Home
News | Cardiovascular Business

July 26, 2016 — The Centers for Medicare & Medicaid Services (CMS) has proposed the creation of new bundled payment ...

Home July 26, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | Angiographic Catheter

Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions) is recalling Angiodynamics Soft Vu Omni Flush Angiographic Catheters due to reports of separation of the tip of the catheter from the main body.

Home July 25, 2016
Home
News | SPECT Imaging

UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-based physician group in Central New Jersey, implemented UltraSPECT’s Xpress3.Cardiac solution at four of their sites.

Home July 25, 2016
Home
News | Patient Engagement

July 22, 2016 — The Centers for Medicare & Medicaid Services (CMS) recently announced 516 awardees in 47 states, Puerto ...

Home July 22, 2016
Home
News | Heart Failure

CardioKinetix Inc. announced this week that 500 patients have received the company’s Parachute Ventricular Partitioning Device for heart failure. Patients have been treated in more than 15 countries, including patients in key international markets where the device is commercially available, and patients enrolled in PARACHUTE IV, the company’s U.S. pivotal trial under investigational device exemption (IDE).

Home July 22, 2016
Home
News | Cardiac Diagnostics

People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a recent study in the Journal of the American College of Cardiology.

Home July 21, 2016
Home
bioresorbable stent, bioabsorbable stent, Absorb BVS, visualizing bioresorbable stents
Feature | Stents Bioresorbable | Alphonse Ambrosia, D.O.

Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of ...

Home July 21, 2016
Home
Subscribe Now